For which patients with resected NSCLC will you offer adjuvant atezolizumab after completion of cisplatin-based adjuvant chemotherapy?  

Will degree of PD-L1 status impact your decision?

Would you ever offer to stage IB patients as per study enrollment?  Do AJCC v8 staging guidelines impact patient selection given study accrued by AJCC v7? Are there patients you would now include/exclude?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Yuma Regional Medical Center Cancer Center
Dr. @Shirish M. Gadgeel, would you be able to comm...
Medical Oncologist at Henry Ford Cancer Institute/Henry Ford Hospital
@Raju K. Vaddepally, I agree with you. The HR for...
Medical Oncologist at Yuma Regional Medical Center Cancer Center
@Shirish M. Gadgeel - Thank you for the feedback! ...
Medical Oncologist at Loyola University Chicago Stritch School of Medicine
@Raju K. Vaddepally here's another discussion that...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Community Practice

Answer from: at Academic Institution